Point-of-care (POC) tests are diagnostic tests that are performed at or near the site where the patient is located. They are performed in decentralized settings, outside of central hospital laboratories or centralized reference laboratories. Growth in POC testing is being fueled by many factors including the growing number of people with diabetes, the globalization of infectious diseases and the associated public health issues, advances in therapies giving physicians more tools for treatment of patients if the doctor is able to rapidly diagnose the problem, the need to monitor an ever-growing group of people with chronic diseases such as cardiovascular diseases, arthritis, cancer and other chronic conditions, and many other factors.
Point of Care Testing (POCT) is attracting considerable investor and industry activity. This Kalorama Information report, The World Market for Point of Care Diagnostics, the result of primary and secondary research into the point of care diagnostics market, presents the most current analysis of the POC Diagnostics industry and the role it plays in medical practice. This report takes an in depth look at the market, technologies, and trends in decentralized testing, looking at both self-testing by patients (also referred to as the over-the-counter (OTC) market, and at point-of-care testing by healthcare professionals.
As part of this report's coverage, the following data is included:
The field for rapid test devices is crowded. This report profiles 140 companies that currently market POC, plus more than 40 additional companies that are developing POC technologies and products or that have just recently entered this market. Companies profiled in this report are using a wide range of different technologies to develop and market rapid tests for much of the range of in vitro diagnostic (IVD) tests that can be performed in centralized laboratories.
The report offers a quantitative assessment of specific markets, worldwide, in U.S. dollars for 2011 to 2016. Information is provided in order to set the status quo of tests and technologies, and to get a look at what is coming. The report also discusses how these tests will affect the economics of healthcare over the near term and longer when possible.
As part of Kalorama Information's comprehensive coverage of Point of Care Diagnostics the following companies are discussed:
Related Reports:The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
May 8, 2013 - KLI5036103 - $4,500.00
The World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices)
May 8, 2013 - KLI5040798 - $3,500.00
The Global Market for Medical Devices, 4th Edition
May 1, 2013 - KLI5030825 - $1,995.00
White Paper: Electronic Medical Records Market Reaches 20 Billion: EMR/EHR Vendors See Gains
Apr 19, 2013 - KLI5023934 - $0.00
The World Market for Dialysis Equipment and Services (United States, Japan, UK, Italy, India, China, Australia and Canada )
Apr 15, 2013 - KLI5019344 - $3,995.00
White Paper: Patient Monitoring Systems - Still The Fastest-Growing Medical Device?
Apr 10, 2013 - KLI5017232 - $0.00
EMR 2013: The Market for Electronic Medical Records
Apr 8, 2013 - KLI5016954 - $3,995.00
Advanced Remote Patient Monitoring Systems
Mar 28, 2013 - KLI4997661 - $4,995.00
The U.S. Market for Urgent Care Centers
Mar 22, 2013 - KLI5003148 - $2,500.00
Retail Clinics: Consumer Attitudes Results of the 2013 Kalorama Survey
Mar 22, 2013 - KLI5007914 - $995.00
Questions?Contact a research specialist >
Most Popular ResearchThe Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition Results of The 2012 Kalorama IVD Procedure Count: White Paper IVD Market Research Bundle (In Vitro Diagnostic Test Markets, BRIC and Other Regional Markets, Biomarker Testing and Other Pharmacodiagnostics) White Paper: Animal Diagnostics: "Sister Market" to IVD? The World Market for Point of Care (POC) Diagnostics Why Epigenomics May Be a Game-Changer in Diagnostics and Pharmaceuticals